Present and future of FDG-PET/CT in ovarian cancer

被引：31
作者：
Kitajima, Kazuhiro [1 ]
Murakami, Koji [2 ]
Sakamoto, Setsu [3 ]
Kaji, Yasushi [4 ]
Sugimura, Kazuro [5 ]
机构：
[1] Inst Biomed Res & Innovat, Dept PET Diag, Chuo Ku, Kobe, Hyogo 6500047, Japan
[2] Keio Univ, Sch Med, Div Nucl Med, Dept Diagnost Radiol, Tokyo, Japan
[3] Dokkyo Med Univ Hosp, PET Ctr, Mibu, Tochigi, Japan
[4] Dokkyo Univ, Sch Med, Dept Radiol, Mibu, Tochigi 32102, Japan
[5] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo 657, Japan
来源：
ANNALS OF NUCLEAR MEDICINE | 2011年 / 25卷 / 03期
关键词：
FDG; PET/CT; Ovarian cancer; Staging; Restaging; POSITRON-EMISSION-TOMOGRAPHY; PET/CONTRAST-ENHANCED CT; RECURRENT OVARIAN; COMPUTED-TOMOGRAPHY; F-18-FDG PET/CT; NEOADJUVANT CHEMOTHERAPY; DIAGNOSTIC-ACCURACY; INTEGRATED PET/CT; THERAPY RESPONSE; NEXT-GENERATION;
D O I：
10.1007/s12149-010-0449-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.
引用
收藏
页码：155 / 164
页数：10
相关论文
共 59 条
[31]   Positron emission tomography in gynecological malignancies [J].
Kumar, Rakesh ;
Chauhan, Anil ;
Jana, Suman ;
Dadparvar, Simin .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (07) :1033-1044
[32]  
Kurosaki H, 2006, ANN NUCL MED, V20, P171
[33]   Use of H2 15O-PET for investigating perfusion changes in pelvic tumors due to regional hyperthermia [J].
Luedemann, L. ;
Sreenivasa, G. ;
Amthauer, H. ;
Michel, R. ;
Gellermann, J. ;
Wust, P. .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2009, 25 (04) :299-308
[34]   Positron emission tomography/computed tomography Imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review [J].
Makhija, S ;
Howden, N ;
Edwards, R ;
Kelley, J ;
Townsend, DW ;
Meltzer, CC .
GYNECOLOGIC ONCOLOGY, 2002, 85 (01) :53-58
[35]   Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer [J].
Mangili, G. ;
Picchio, M. ;
Sironi, S. ;
Vigano, R. ;
Rabaiotti, E. ;
Bornaghi, D. ;
Bettinardi, V. ;
Crivellaro, C. ;
Messa, C. ;
Fazio, F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) :658-666
[36]   Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI [J].
Nam, Eun Ji ;
Yun, Mi Jin ;
Oh, Young Taik ;
Kim, Jae Wook ;
Kim, Jae Hoon ;
Kim, Sunghoon ;
Jung, Yong Wook ;
Kim, Sang Wun ;
Kim, Young Tae .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :389-394
[37]   Role of diffusion-weighted imaging in the diagnosis of gynecological diseases [J].
Namimoto, Tomohiro ;
Awai, Kazuo ;
Nakaura, Takeshi ;
Yanaga, Yumi ;
Hirai, Toshinori ;
Yamashita, Yasuyuki .
EUROPEAN RADIOLOGY, 2009, 19 (03) :745-760
[38]   18F-FDG PET/CT in the evaluation of recurrent ovarian cancer:: a prospective study on forty-one patients [J].
Nanni, C ;
Rubello, D ;
Farsad, M ;
De Iaco, P ;
Sansovini, M ;
Erba, P ;
Rampin, L ;
Mariani, G ;
Fanti, S .
EJSO, 2005, 31 (07) :792-797
[39]   Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET [J].
Nishiyama, Yoshihiro ;
Yamamoto, Yuka ;
Kanenishi, Kenji ;
Ohno, Masami ;
Hata, Toshiyuki ;
Kushida, Yoshio ;
Haba, Reiji ;
Ohkawa, Motoomi .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) :287-295
[40]   LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTOR-ANALYSIS IN ADVANCED OVARIAN-CARCINOMA - THE GYNECOLOGIC-ONCOLOGY-GROUP EXPERIENCE [J].
OMURA, GA ;
BRADY, MF ;
HOMESLEY, HD ;
YORDAN, E ;
MAJOR, FJ ;
BUCHSBAUM, HJ ;
PARK, RC .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) :1138-1150
123456